Coherus BioSciences, Inc.

CHRS

Sector
Healthcare

Industry
Biotechnology

Website
coherus.com




Buy / Sell (dollars)

1 Month

23.6% 23.6% Complete (success)
76.4% 76.4% Complete (danger)
$31,747.95
avg. $31,747.95
$102,537.96
avg. $102,537.96

Buy/Sell Ratio

0.31

Transactions

4

Filers

1

3 Month

23.3% 23.3% Complete (success)
76.7% 76.7% Complete (danger)
$139,494.30
avg. $46,498.10
$458,947.23
avg. $152,982.41

Buy/Sell Ratio

0.304

Transactions

14

Filers

2

12 Month

1% 1% Complete (success)
99% 99% Complete (danger)
$145,745.55
avg. $12,145.46
$13.747M
avg. $1.146M

Buy/Sell Ratio

0.011

Transactions

30

Filers

11

24 Month

1.1% 1.1% Complete (success)
98.9% 98.9% Complete (danger)
$165,732.35
avg. $6,905.51
$14.379M
avg. $599,142.78

Buy/Sell Ratio

0.012

Transactions

48

Filers

15

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers